quadgram

This is a table of type quadgram and their frequencies. Use it to search & browse the list to learn more about your study carrel.

quadgram	frequency
middle east respiratory syndrome	3162
east respiratory syndrome coronavirus	2545
of middle east respiratory	1081
severe acute respiratory syndrome	457
respiratory syndrome coronavirus infection	402
the middle east respiratory	256
respiratory syndrome coronavirus in	251
with middle east respiratory	235
in the middle east	194
for middle east respiratory	174
outbreak of middle east	158
of severe acute respiratory	155
acute respiratory syndrome coronavirus	144
of the middle east	133
syndrome coronavirus infection in	125
patients with middle east	124
the republic of korea	119
in the republic of	112
kingdom of saudi arabia	110
of a novel coronavirus	107
cases of middle east	101
respiratory syndrome coronavirus infections	91
arabia middle east respiratory	91
in dromedary camels in	91
saudi arabia middle east	91
a novel coronavirus from	87
acute respiratory distress syndrome	86
pneumonia in saudi arabia	84
case of middle east	82
novel coronavirus from a	82
from a man with	81
isolation of a novel	81
with pneumonia in saudi	80
a man with pneumonia	80
infection prevention and control	80
coronavirus from a man	80
man with pneumonia in	79
hospital outbreak of middle	78
the world health organization	77
the end of the	69
east respiratory syndrome in	69
in the lungs of	68
coronavirus in dromedary camels	68
the kingdom of saudi	67
critically ill patients with	67
respiratory syndrome coronavirus disease	66
and clinical characteristics of	66
infection in dromedary camels	65
outbreak in south korea	65
with severe acute respiratory	61
antibodies in dromedary camels	61
in the united states	59
coronavirus middle east respiratory	59
characteristics of cases of	58
the middle east and	57
clinical characteristics of cases	56
in the arabian peninsula	56
disease control and prevention	56
in saudi arabia middle	56
cluster of middle east	53
transmission of middle east	53
of cases of middle	53
coronavirus disease from saudi	52
disease from saudi arabia	52
on the basis of	52
syndrome coronavirus disease from	52
family cluster of middle	52
from the middle east	51
for disease control and	51
infection with middle east	51
outbreak in the republic	51
the severe acute respiratory	50
mers coronavirus in dromedary	50
of the bronze age	50
study middle east respiratory	48
on the other hand	48
end of the bronze	47
centers for disease control	47
camels in saudi arabia	47
as well as the	46
the united arab emirates	46
in the respiratory tract	45
in the kingdom of	45
syndrome coronavirus in dromedary	44
human transmission of mers	44
dromedary camels in saudi	43
respiratory syndrome coronavirus spike	43
coronavirus infection in dromedary	42
the lower respiratory tract	42
ill patients with middle	42
a functional receptor for	41
outbreaks of middle east	39
of critically ill patients	38
respiratory syndrome coronavirus middle	38
respiratory syndrome coronavirus and	38
syndrome coronavirus middle east	38
at the end of	37
with the middle east	37
to the middle east	36
transmission of mers coronavirus	36
at the time of	35
congo hemorrhagic fever virus	35
a comparative serological study	35
outcomes of critically ill	35
clinical course and outcomes	35
and outcomes of critically	35
course and outcomes of	35
confirmed cases of mers	35
serum antibodies in dromedary	35
the spike protein of	35
of influenza a virus	34
link to health care	34
functional receptor for the	34
to health care facilities	34
as well as in	34
of a case of	34
east and southeast asia	34
acute respiratory syndrome in	34
in patients with severe	33
coronavirus in saudi arabia	33
is a functional receptor	33
a link to health	33
cov outbreak in jeddah	33
for the treatment of	33
patients with severe acute	33
coronavirus neutralising serum antibodies	32
neutralising serum antibodies in	32
in middle east respiratory	32
respiratory syndrome coronavirus neutralising	32
syndrome coronavirus neutralising serum	32
transcription polymerase chain reaction	31
camels middle east respiratory	31
middle eastern respiratory syndrome	31
for the development of	31
coronavirus infection in the	31
a systematic review and	31
lower respiratory tract infection	30
antibodies against mers coronavirus	30
cov outbreak in south	30
in the absence of	30
international catalogue of arboviruses	30
against mers coronavirus in	30
severe middle east respiratory	30
outcomes of patients with	30
against middle east respiratory	30
the upper respiratory tract	29
east respiratory syndrome outbreak	29
cases of infection with	29
with acute respiratory distress	29
in the treatment of	29
in saudi arabia in	29
syndrome coronavirus spike protein	29
of patients with middle	28
korea middle east respiratory	28
associated outbreak of middle	28
receptor for the emerging	28
a case of middle	28
peptidase is a functional	28
the emerging human coronavirus	28
in vitro and in	28
dipeptidyl peptidase is a	28
saudi ministry of health	28
a family cluster of	28
for the emerging human	28
to middle east respiratory	28
human middle east respiratory	28
the risk of mers	27
cov infection in dromedary	27
imported case of middle	27
virological analysis of a	27
analysis of a case	27
clinical features and virological	27
dromedary camels middle east	27
caused by a novel	27
respiratory syndrome coronavirus transmission	27
and virological analysis of	27
in the united arab	27
and outcomes of patients	27
a large number of	27
in the development of	27
features and virological analysis	27
in upper respiratory tract	26
hospital in saudi arabia	26
prevalence of middle east	26
respiratory syndrome coronavirus outbreak	26
of the spike protein	26
on the territory of	26
s f cd l	26
modified vaccinia virus ankara	26
in the context of	26
syndrome coronavirus in the	26
cov infection in a	26
in combination with ribavirin	26
in patients with middle	26
coronavirus in dromedary camel	26
syndrome coronavirus infections in	26
transmission of the virus	26
knowledge and data gaps	25
the arabian peninsula and	25
gaps of middle east	25
mers outbreak in korea	25
cov in upper respiratory	25
of knowledge and data	25
a fatal case of	25
and data gaps of	25
data gaps of middle	25
state of knowledge and	25
ribavirin and interferon alfa	24
infection in the united	24
rna was detected in	24
model for middle east	24
in saudi arabia and	24
experience in saudi arabia	24
and postexposure efficacy of	24
clinical aspects and outcomes	24
in the healthcare setting	24
coronavirus neutralizing antibodies in	24
risk factors for primary	24
have been shown to	24
for the presence of	24
aspects and outcomes of	24
cov infection in humans	24
a retrospective cohort study	24
for patients with middle	24
ribavirin and interferon therapy	23
genomic characterization of a	23
respiratory syndrome coronavirus pneumonia	23
human infection with mers	23
in jeddah and riyadh	23
the saudi ministry of	23
and cellular immune responses	23
respiratory distress syndrome in	23
and evolution of the	23
was isolated from the	23
for the detection of	23
to the world health	23
for primary middle east	23
factors for primary middle	23
respiratory syndrome coronavirus antibodies	23
a mouse model for	23
syndrome coronavirus infection and	23
patients infected with the	23
primary middle east respiratory	23
and middle east respiratory	23
associated with acute respiratory	23
during the outbreak in	23
the first imported case	23
center experience in saudi	23
with mers coronavirus after	22
clinical features and viral	22
replication and shedding of	22
respiratory tract infection in	22
report of nosocomial transmission	22
the presence of mers	22
of two cases of	22
from a dromedary camel	22
from dromedary camels in	22
have been reported to	22
syndrome middle east respiratory	22
influenza a h n	22
mers coronavirus after exposure	22
features and viral diagnosis	22
of patients with mers	22
syndrome coronavirus antibodies in	22
of a newly discovered	22
and viral diagnosis of	22
for severe middle east	22
eastern respiratory syndrome coronavirus	22
a newly discovered coronavirus	22
two cases of infection	22
viral diagnosis of two	22
coronavirus after exposure to	22
after exposure to infected	22
diagnosis of two cases	22
it is important to	22
a report of nosocomial	22
the total number of	22
of infection with middle	22
strains were isolated from	22
and shedding of mers	22
infection with mers coronavirus	22
by a novel coronavirus	22
exposure to infected camels	22
respiratory syndrome coronavirus by	22
human betacoronavirus c emc	21
newly discovered coronavirus associated	21
was detected in the	21
in dromedary camel herd	21
characterization of a newly	21
improves outcome in mers	21
the similarity of the	21
the infection rate of	21
of the virus in	21
of west nile virus	21
respiratory syndrome coronavirus from	21
and reviewed the manuscript	21
in patients infected with	21
coronavirus associated with acute	21
of the novel human	21
ribavirin improves outcome in	21
virus was detected in	21
and ribavirin improves outcome	21
syndrome coronavirus in saudi	21
respiratory syndrome middle east	21
discovered coronavirus associated with	21
coronaviruses in dromedary camels	21
and outcomes of middle	21
b and ribavirin improves	21
distress syndrome in humans	21
isolation and characterization of	21
outcomes of middle east	21
reduces virus excretion after	20
in the far east	20
vaccine reduces virus excretion	20
was found to be	20
syndrome coronavirus outbreak in	20
of the s protein	20
of novel human coronavirus	20
treatment of middle east	20
in an affected region	20
evolution of the middle	20
systematic review and meta	20
as a result of	20
species in an affected	20
the ministry of health	20
virus excretion after mers	20
an affected region in	20
complete genome sequence of	20
investigation middle east respiratory	20
the first case of	20
major livestock species in	20
serology in major livestock	20
in the upper respiratory	20
progression to respiratory failure	20
risk factors for mers	20
testing for middle east	20
syndrome coronavirus infection during	20
livestock species in an	20
coronavirus outbreak in the	20
respiratory illness caused by	20
cases have been reported	20
binding domain of the	20
mouse model of mers	20
in major livestock species	20
in the case of	20
in east and southeast	20
affected region in jordan	20
respiratory syndrome in the	20
closely related to the	19
coronavirus species and recombination	19
a for severe middle	19
the s protein of	19
domestic livestock in saudi	19
risk factors for middle	19
in the spike protein	19
syndrome coronavirus illness in	19
livestock in saudi arabia	19
antibodies in saudi arabia	19
coronavirus in jeddah and	19
in the south of	19
coronavirus seroprevalence in domestic	19
coronavirus antibodies in saudi	19
camel coronavirus species and	19
the emergence of the	19
model of middle east	19
presence of middle east	19
dromedary camels in the	19
a descriptive genomic study	19
a novel human coronavirus	19
interferon therapy in patients	19
was isolated from a	19
a total of patients	19
the case fatality rate	19
and interferon therapy in	19
human neutralizing monoclonal antibodies	19
a combination of interferon	19
and recombination of mers	19
three camel coronavirus species	19
mouse model of middle	19
in domestic livestock in	19
species and recombination of	19
were found to be	19
of a fatal case	19
unrecognized asymptomatic or mild	19
covs in saudi arabia	19
south and east asia	19
other viruses of vertebrates	19
novel middle east respiratory	19
therapy in patients infected	19
certain other viruses of	19
syndrome coronavirus in bats	19
study of outbreaks of	19
in the emergency room	19
have been reported in	19
infected with the middle	19
the onset of symptoms	19
infections in health care	19
seroprevalence in domestic livestock	19
circulation of three camel	19
isolation of mers coronavirus	19
upper respiratory tract of	19
coronavirus illness in humans	19
factors for middle east	19
respiratory syndrome coronavirus illness	19
of mers coronavirus from	19
of three camel coronavirus	19
in the common marmoset	19
predictive factors for pneumonia	18
related to a likely	18
associated middle east respiratory	18
likely unrecognized asymptomatic or	18
mers coronaviruses in dromedary	18
coronavirus from a dromedary	18
in addition to the	18
infections related to a	18
coronavirus infections related to	18
mers coronavirus neutralizing antibodies	18
of the first imported	18
acute middle east respiratory	18
in the near east	18
model of common marmoset	18
type i and ii	18
of influenza a viruses	18
transmissibility of middle east	18
of outbreaks of middle	18
based vaccine reduces virus	18
a likely unrecognized asymptomatic	18
for the middle east	18
of the international committee	18
in the lungs and	18
days after symptom onset	18
the development of a	18
a member of the	18
one of the most	18
asymptomatic or mild case	18
to a likely unrecognized	18
a high level of	18
syndrome coronavirus infections related	18
mers coronavirus from a	18
have been reported from	18
confirmed cases of middle	18
the epidemiology of mers	18
respiratory syndrome coronavirus replication	18
the risk of death	18
transient lower respiratory tract	18
primate model of common	18
in the lower respiratory	18
b improves outcome of	18
syndrome coronavirus in jeddah	18
improves outcome of mers	18
exposure in an emergency	17
infection in rhesus macaques	17
syndrome in hong kong	17
of human middle east	17
combination with ribavirin to	17
of viral rna in	17
with ribavirin to treat	17
east respiratory syndrome middle	17
pneumonia development and progression	17
confirmation of novel human	17
patient exposure in an	17
the east asian tigers	17
macaques and common marmosets	17
catalogue of arboviruses and	17
factors for pneumonia development	17
the human respiratory tract	17
are more likely to	17
potential conflicts of interest	17
single patient exposure in	17
viral rna was detected	17
in an emergency room	17
vitro and in vivo	17
lopinavir ritonavir or interferon	17
identification of a novel	17
treat middle east respiratory	17
patients with severe mers	17
respiratory syndrome coronavirus mers	17
neutralizing antibodies against mers	17
to treat middle east	17
assays for laboratory confirmation	17
a high prevalence of	17
and progression to respiratory	17
ribavirin to treat middle	17
generation of a mouse	17
based study of outbreaks	17
infectious virus was detected	17
coronavirus infection and disease	17
following a single patient	17
laboratory confirmation of novel	17
respiratory syndrome in hong	17
illness caused by a	17
from the blood of	17
prevention and control measures	17
risk factors of mers	17
associated with middle east	17
with lopinavir ritonavir or	17
treatment with lopinavir ritonavir	17
for laboratory confirmation of	17
a single patient exposure	17
rapid generation of a	17
the south korean outbreak	17
the median incubation period	17
with severe disease and	17
study of hospitalized patients	17
severe disease and death	17
south korea middle east	17
rhesus macaques and common	17
by a combination of	17
a in combination with	16
a nonhuman primate model	16
the outbreak in the	16
coronavirus in household contacts	16
and transmission of middle	16
binding domain of mers	16
of a novel human	16
tract of inoculated dromedary	16
findings of a fatal	16
the receptor binding domain	16
of inoculated dromedary camels	16
monoclonal antibody against mers	16
were detected in the	16
on the epidemiology of	16
of patients infected with	16
is one of the	16
efficacy of fully human	16
parts of the world	16
nonhuman primate model of	16
tract infection in rhesus	16
middle east respiratory coronavirus	16
causes transient lower respiratory	16
development and progression to	16
ultrastructural findings of a	16
a middle east respiratory	16
the rest of the	16
epidemiology of middle east	16
respiratory syndrome coronavirus a	16
cause of severe acute	16
been shown to be	16
of the severe acute	16
outbreak investigation middle east	16
infection in a nonhuman	16
h n strains were	16
an outbreak investigation middle	16
to the arabian peninsula	16
that they have no	16
report of the international	16
inhibitors of middle east	16
respiratory tract of inoculated	16
is closely related to	16
in health care workers	16
declare that they have	16
the respiratory tract of	16
highly pathogenic avian influenza	16
and shortness of breath	16
admission to the icu	16
reported to the world	16
of a mouse model	16
control study of hospitalized	16
humanized mouse model of	16
in dromedary camels middle	16
the emergence of mers	16
in a nonhuman primate	16
outbreak of severe acute	16
mouse model for middle	16
plague of the philistines	16
who has granted medrxiv	15
committee on taxonomy of	15
to display the preprint	15
fatal case of middle	15
and the middle east	15
coronavirus replication by a	15
have been identified in	15
copyright holder for this	15
the international committee on	15
a prospective descriptive study	15
and lower respiratory tract	15
a transgenic mouse model	15
ivanovsky institute of virology	15
and phylogenetic analysis of	15
in dromedary camels and	15
granted medrxiv a license	15
coronavirus among dromedary camels	15
the course of the	15
in a patient with	15
respiratory syndrome corona virus	15
dromedary camels in egypt	15
pipistrellus bat coronavirus hku	15
a license to display	15
the european part of	15
replication by a combination	15
findings from a retrospective	15
lethal pneumonia in the	15
geographic distribution of mers	15
in patients with mers	15
the preprint in perpetuity	15
has granted medrxiv a	15
the s subunit of	15
outside the arabian peninsula	15
medrxiv a license to	15
mers coronavirus infection in	15
in the form of	15
an epidemiological outbreak study	15
were included in the	15
protein in a novel	15
international committee on taxonomy	15
novel humanized mouse model	15
lungs of rhesus macaques	15
of fully human antibodies	15
from a retrospective investigation	15
epidemiological findings from a	15
cov outbreak following a	15
emergency room in south	15
n strains were isolated	15
the centers for disease	15
license to display the	15
the novel human betacoronavirus	15
of mers coronavirus among	15
antibodies against spike protein	15
south and east asian	15
mers coronavirus among dromedary	15
the outbreak in south	15
were negative for mers	15
other parts of the	15
a median of days	15
it is possible that	15
in a novel humanized	15
spike protein in a	15
the coronavirus study group	15
the extent of the	15
estimation of pandemic risk	15
in a mouse model	15
stability of middle east	15
cellular immune responses in	15
fully human antibodies against	15
respiratory syndrome coronavirus vaccine	15
for severe acute respiratory	15
the basis of the	15
on taxonomy of viruses	15
the lungs of rhesus	15
causes lethal pneumonia in	15
the copyright holder for	15
interhuman transmissibility of middle	15
countries in the middle	15
and ultrastructural findings of	15
distribution of mers coronavirus	15
the late bronze age	15
dromedary camels and humans	15
the plague of the	15
an emergency room in	15
which was not peer	15
respiratory syndrome in a	15
pneumonia in the common	15
a novel humanized mouse	15
european part of russia	15
by the world health	15
tested positive for mers	15
holder for this preprint	15
human antibodies against spike	15
postexposure efficacy of fully	15
display the preprint in	15
infection middle east respiratory	15
cov causes lethal pneumonia	15
outbreak following a single	15
the spread of the	15
against spike protein in	15
in health care settings	15
room in south korea	15
the spread of mers	15
a h n virus	15
syndrome in the republic	14
a novel coronavirus associated	14
tertiary care hospital in	14
load with severe disease	14
neutralizing antibodies in camels	14
disease prevention and control	14
the united states and	14
coronavirus using microneutralisation and	14
an important role in	14
respiratory syndrome coronavirus through	14
in the united kingdom	14
the number of mers	14
reported in saudi arabia	14
these results suggest that	14
the lungs of the	14
coronavirus infections in health	14
syndrome coronavirus through its	14
detection of middle east	14
the gene source of	14
outside the middle east	14
clinical and laboratory findings	14
virus neutralisation assays reveal	14
cov virus load with	14
prevalence of antibody in	14
the authors declare no	14
natural foci of arboviruses	14
microneutralisation and pseudoparticle virus	14
respiratory syndrome coronavirus causes	14
has been shown to	14
at the same time	14
on middle east respiratory	14
immigration to illness onset	14
neutralisation assays reveal a	14
healthcare worker and family	14
a single dose of	14
were observed in the	14
have been detected in	14
an outbreak of middle	14
days from onset to	14
of the united states	14
have been found in	14
of the russian plain	14
studies are needed to	14
inhibition of middle east	14
and laboratory findings of	14
from immigration to illness	14
an intensive care unit	14
restriction of middle east	14
coronavirus through its receptor	14
association of higher mers	14
the novel middle east	14
alpha b and ribavirin	14
for mers coronavirus using	14
mortality risk factors for	14
coronavirus associated with severe	14
the southern part of	14
virus load with severe	14
host species restriction of	14
in abu dhabi emirate	14
using microneutralisation and pseudoparticle	14
immune responses in mice	14
laboratory testing for middle	14
reveal a high prevalence	14
during the course of	14
species restriction of middle	14
in the astrakhan region	14
in accordance with the	14
more likely to be	14
in the instillation group	14
severe respiratory illness caused	14
in saudi arabia mers	14
the pathogenesis of mers	14
as the result of	14
can be used to	14
upper and lower respiratory	14
authors declare that they	14
novel coronavirus associated with	14
seroepidemiology for mers coronavirus	14
of the extent of	14
rift valley fever virus	14
and pseudoparticle virus neutralisation	14
of antibody in dromedary	14
antibody in dromedary camels	14
as the gene source	14
emergence of middle east	14
mers coronavirus using microneutralisation	14
the phylogenetic tree of	14
isolated from a patient	14
assays reveal a high	14
pseudoparticle virus neutralisation assays	14
for the prevention of	14
in dromedary camels from	14
nasal and throat swabs	14
high prevalence of antibody	14
risk factors for transmission	13
a patient who died	13
of the s subunit	13
and human coronavirus oc	13
worker and family contacts	13
fever with renal syndrome	13
humans and dromedary camels	13
coronavirus in patients with	13
of a transgenic mouse	13
of japanese encephalitis virus	13
screening for middle east	13
the intensive care unit	13
under the control of	13
detection of a novel	13
coronavirus infection in hospital	13
infection in hospital patients	13
of transmission of mers	13
descriptive study middle east	13
emerging middle east respiratory	13
to severe acute respiratory	13
a novel coronavirus in	13
with the exception of	13
transcriptase polymerase chain reaction	13
in the aerosol group	13
clinical presentation and outcomes	13
presentation and outcomes of	13
respiratory syndrome coronavirus during	13
high case fatality rate	13
a hospital outbreak of	13
does not result in	13
is made available under	13
related viruses in bats	13
hemorrhagic fever with renal	13
syndrome coronavirus spike glycoprotein	13
de wit et al	13
the authors declare that	13
a b and ribavirin	13
serological study middle east	13
relative of human middle	13
reverse transcription polymerase chain	13
to better understand the	13
under a author funder	13
syndrome coronavirus in bat	13
of this study was	13
the middle east area	13
to the united states	13
hospital patients and their	13
their healthcare worker and	13
and their healthcare worker	13
global alert and response	13
patients and their healthcare	13
license it is made	13
during the study period	13
human coronavirus oc antigen	13
the severity of the	13
in the treatment group	13
was first reported in	13
under different environmental conditions	13
centre for disease prevention	13
international license it is	13
replication of middle east	13
coronavirus infection middle east	13
transmission and evolution of	13
time from immigration to	13
cov infection in the	13
european centre for disease	13
in the near future	13
with the use of	13
it is made available	13
a total of cases	13
close relative of human	13
from the first imported	13
for disease prevention and	13
made available under a	13
at increased risk of	13
infections in healthcare settings	13
they have no competing	13
been reported to the	13
available under a author	13
in saudi arabia the	13
in hospital patients and	13
in south and east	13
to be associated with	13
of the incubation period	13
to an intensive care	13
in the circulation of	13
a systematic review of	13
extent of the epidemic	13
of the risk of	13
strain was isolated from	13
n and h n	12
literature update and risk	12
prevention and control guidelines	12
infection in south korea	12
for pneumonia development and	12
and the risk of	12
than that of the	12
a conspecific virus from	12
monoclonal antibodies to the	12
h n and h	12
at the university of	12
the beginning of the	12
in the vaccinated group	12
characterization of a novel	12
laboratory findings of the	12
transmission characteristics of mers	12
domain of the spike	12
coronavirus by characterization of	12
in the human respiratory	12
definition for reporting to	12
by characterization of a	12
middle east and south	12
i and ii pneumocytes	12
as part of the	12
the emerging middle east	12
were positive for mers	12
virus was isolated from	12
concept of human security	12
the territory of the	12
the mean age of	12
first imported case of	12
update and risk assessment	12
guidance for the public	12
there is no evidence	12
findings of the first	12
severe acute respiratory infections	12
of the disease in	12
is associated with a	12
characterization of a conspecific	12
in any of the	12
quantification of the extent	12
has not yet been	12
phylogenetic analysis of the	12
outbreaks in the middle	12
have also been reported	12
of proinflammatory cytokines and	12
ministry of health and	12
can be found in	12
case definition for reporting	12
sars in the healthcare	12
hospital in south korea	12
in line with the	12
a wide range of	12
were approved by the	12
was supported by the	12
infection control and prevention	12
and guidance for the	12
care hospital in saudi	12
referral hospital in saudi	12
coronaviruses as the gene	12
of the coronavirus study	12
characteristics of mers and	12
the results of the	12
was first isolated in	12
state collection of viruses	12
human coronavirus by real	12
have no competing interests	12
protein of middle east	12
of mers and sars	12
conspecific virus from an	12
virus from an african	12
date of symptom onset	12
evidence of middle east	12
play an important role	12
novel human coronavirus by	12
of a conspecific virus	12
ninth report of the	12
rooting the phylogenetic tree	12
mers and sars in	12
approved the final manuscript	12
novel human coronavirus mers	12
associated with severe acute	12
comparative serological study middle	12
for the first time	12
respiratory syndrome coronavirus fusion	12
east and south korea	12
infected with middle east	12
the amino acid sequence	12
west nile virus in	12
summary of current situation	12
respiratory syndrome coronavirus as	12
imported middle east respiratory	12
the duration of the	12
of three segments of	12
transgenic mouse model of	12
and approved the final	12
the origin of the	12
reported from saudi arabia	12
from an african bat	12
the risk factors for	12
in balb c mice	12
and sars in the	12
infection during the outbreak	12
on the th of	12
from bench to bedside	11
of the arabian peninsula	11
syndrome coronavirus infection middle	11
of the index case	11
origin and animal reservoir	11
and is strongly inhibited	11
patients with the middle	11
in type i and	11
yield in patients with	11
syndrome coronavirus and the	11
cov rna was detected	11
amino acid sequence of	11
for the emerging middle	11
shedding and antibody response	11
antivirals for the emerging	11
for a long time	11
coronavirus replication induces severe	11
was not detected in	11
of arboviruses including certain	11
this study was to	11
genome sequence of middle	11
cov infections have been	11
the treatment of mers	11
and its receptor cd	11
to the viral spike	11
hospitalized patients with middle	11
consists of three segments	11
and genome fraction yield	11
in south korea middle	11
antibody response in patients	11
the role of the	11
is strongly inhibited by	11
strains were isolated in	11
russian state collection of	11
and risk factors for	11
of the first mers	11
a better understanding of	11
the dynamics of the	11
at the beginning of	11
a humanized neutralizing antibody	11
fraction yield in patients	11
in the east asian	11
contact with dromedary camels	11
it was found that	11
tree of middle east	11
induces severe in vitro	11
international severe acute respiratory	11
humoral and cellular immune	11
were more likely to	11
coronavirus infections in healthcare	11
spectrum antivirals for the	11
to the development of	11
lower respiratory tract specimens	11
from the arabian peninsula	11
of the authors and	11
viral shedding and antibody	11
inhibited by cyclosporin a	11
zoonotic betacoronavirus causing sars	11
the concept of human	11
of novel coronavirus infections	11
and the transfer of	11
it should be noted	11
and public health authorities	11
from the kingdom of	11
the prevalence of mers	11
it is likely that	11
sequence of middle east	11
has been detected in	11
have been associated with	11
upe and orf a	11
evaluation of candidate vaccine	11
a broad spectrum of	11
replication induces severe in	11
of the virus to	11
genome fraction yield in	11
from symptom onset to	11
others viruses of vertebrates	11
syndrome coronavirus replication in	11
features of the first	11
work was supported by	11
for reporting to who	11
at high risk of	11
syndrome coronavirus by characterization	11
catalogue of arboviruses including	11
higher than that of	11
there is a need	11
was first isolated from	11
treatment of severe acute	11
severe acute respiratory infection	11
a large tertiary care	11
response in patients with	11
in vitro cytopathology and	11
orf a and orf	11
recombinant modified vaccinia virus	11
infection in dialysis patients	11
vitro cytopathology and is	11
those of the authors	11
and to a lesser	11
surveillance of middle east	11
cyclosporin a or interferon	11
congo hemorrhagic fever in	11
of personal protective equipment	11
and antibody response in	11
glycoproteins gn and gc	11
animal model of mers	11
patients in saudi arabia	11
the early stages of	11
the genome of the	11
viral loads in the	11
neutralizing antibodies in mice	11
declare no competing interests	11
prophylactic and postexposure efficacy	11
of the united nations	11
generation of a transgenic	11
phylogenetic tree of middle	11
vaccine approaches for mers	11
syndrome coronavirus fusion inhibitor	11
as one of the	11
some others viruses of	11
are those of the	11
strongly inhibited by cyclosporin	11
cov middle east respiratory	11
arboviruses and some others	11
candidate vaccine approaches for	11
and some others viruses	11
by cyclosporin a or	11
revision of the manuscript	11
are not susceptible to	11
of arboviruses and some	11
arboviruses including certain other	11
of candidate vaccine approaches	11
syndrome coronavirus infection clinical	11
severe in vitro cytopathology	11
including certain other viruses	11
infection in saudi arabia	11
cytopathology and is strongly	11
the number of cases	11
camels antibodies against mers	11
another zoonotic betacoronavirus causing	11
inflammatory cytokines and chemokines	11
patients with middle eastern	10
include homologues of human	10
to rechallenge of alpacas	10
patients with confirmed mers	10
is known about the	10
antibody against mers coronavirus	10
respiratory syndrome in taif	10
transgenic mice infected with	10
birds and the transfer	10
treatment of patients with	10
protective efficacy of recombinant	10
and the use of	10
of alpacas with middle	10
to a hospital outbreak	10
higher than that in	10
cases in the middle	10
cov infection have been	10
a limited number of	10
cases in saudi arabia	10
alpacas with middle east	10
in the north of	10
envelope glycoproteins gn and	10
republic of korea and	10
food and agriculture organization	10
basis of binding between	10
isl israel epi isl	10
the transmission of mers	10
hospital outbreaks of mers	10
the emergence of a	10
binding between novel human	10
of coronaviruses in bats	10
of the virus and	10
in the transmission of	10
recommendations for hospitalized patients	10
are likely to be	10
an emerging coronavirus infection	10
was originally isolated from	10
no conflict of interest	10
human monoclonal antibody protects	10
cov spike protein induces	10
molecular basis of binding	10
coronavirus infection tracked by	10
of patients presenting with	10
virus cultured from dromedary	10
for patients with severe	10
of the cases were	10
syndrome coronavirus by human	10
admitted to an intensive	10
in a large tertiary	10
the south and east	10
by human monoclonal antibodies	10
report of two cases	10
updated information on the	10
from patients with pneumonia	10
little is known about	10
infection tracked by the	10
neutralizing monoclonal antibody specifically	10
of infection control measures	10
between novel human coronavirus	10
of inflammatory cytokines and	10
a descriptive study middle	10
used in this study	10
most closely related to	10
to the onset of	10
the arab middle east	10
infection and response to	10
of binding between novel	10
of the sars coronavirus	10
are summarized in table	10
postexposure efficacy of a	10
returning from the middle	10
there was no evidence	10
phylogenetic analysis based on	10
novel human coronavirus emc	10
on the surface of	10
in most of the	10
was first detected in	10
for hospitalized patients with	10
the majority of the	10
a major role in	10
referral center in the	10
response to rechallenge of	10
and characterization of a	10
of the caspian sea	10
delivering middle east respiratory	10
cytokines and chemokines in	10
fatal and nonfatal cases	10
a high mortality rate	10
patients admitted to an	10
days prior to the	10
neutralizing monoclonal antibodies to	10
experimental infection and response	10
the metaphor of the	10
and severe acute respiratory	10
syndrome coronavirus in alpacas	10
efficacy of recombinant modified	10
presence of viral rna	10
the fact that the	10
human cases of mers	10
the detection of mers	10
the pathogenesis of sars	10
monoclonal antibody specifically targeting	10
in the present study	10
syndrome in a large	10
more likely to have	10
control recommendations for hospitalized	10
multifacility outbreak of middle	10
syndrome coronavirus quasispecies that	10
us centers for disease	10
it is difficult to	10
control study of patients	10
in the aftermath of	10
authors declare no competing	10
from a patient who	10
asymptomatic or mildly symptomatic	10
probable or confirmed cases	10
of human security in	10
diagnosis of middle east	10
cov by human neutralizing	10
the innate immune response	10
spread of middle east	10
a and orf b	10
a potent human monoclonal	10
and response to rechallenge	10
with those of other	10
replication in cell culture	10
the viral spike glycoprotein	10
isl turkey epi isl	10
the russian far east	10
that include homologues of	10
and implications for the	10
the size of the	10
the majority of cases	10
cultured from dromedary camels	10
of birds and the	10
the median age of	10
for critically ill patients	10
a preliminary report of	10
our understanding of the	10
the use of convalescent	10
the distribution of the	10
human monoclonal antibody against	10
coronavirus quasispecies that include	10
epi isl turkey epi	10
migration of birds and	10
isl unitedarabemirates epi isl	10
analysis and virus cultured	10
announcement of the coronavirus	10
by human neutralizing monoclonal	10
as a possible cause	10
that the virus is	10
human isolates revealed through	10
efficacy of a potent	10
better understanding of the	10
in the breath of	10
be one of the	10
in other parts of	10
h n avian influenza	10
isl saudiarabia epi isl	10
the time from immigration	10
of a potent human	10
and the role of	10
respiratory syndrome coronavirus antibody	10
tracked by the crowd	10
emerging coronavirus infection tracked	10
of human isolates revealed	10
has been associated with	10
coronavirus replication in cell	10
in a number of	10
a possible cause of	10
epi isl israel epi	10
antibodies were detected in	10
respiratory syndrome coronavirus receptor	10
novel coronavirus in patients	10
upper respiratory tract and	10
detected in the lungs	10
levels of infectious virus	10
in dromedary camels mers	10
direct and indirect contact	10
in south korea in	10
in humans middle east	10
the epidemiology of middle	10
saudi arabia evidence for	10
epi isl saudiarabia epi	10
has been isolated from	10
in the sera of	10
was observed in the	10
potent human monoclonal antibody	10
a report of cases	10
in the vicinity of	10
korea centers for disease	10
first confirmed cases of	10
respiratory syndrome coronavirus quasispecies	10
read and approved the	10
triple combination antiviral regimen	10
emerg infect dis doi	10
quasispecies that include homologues	10
with middle eastern respiratory	10
transfer of the infectious	10
epi isl unitedarabemirates epi	10
humans middle east respiratory	10
the posterior probability of	10
in or near the	10
serological evidence of mers	10
and virus cultured from	10
study ribavirin and interferon	10
course of the disease	10
would like to thank	10
respiratory disease associated with	10
of the infectious agents	10
cov and its receptor	10
large tertiary care hospital	10
man of east asia	10
betacoronavirus lineage c viruses	10
a role in the	10
foci of arboviruses in	10
in the number of	10
in the presence of	10
therapy for critically ill	10
and united arab emirates	10
and characterization of viruses	10
detection of the middle	10
rechallenge of alpacas with	10
of viral shedding and	10
the mers outbreak in	10
potent neutralization of mers	10
homologues of human isolates	10
the transfer of the	10
reverse transcriptase polymerase chain	10
a significant increase in	10
antibodies to the viral	10
of recombinant modified vaccinia	10
information on the epidemiology	10
center in the kingdom	10
of dpp in the	9
levels of viral rna	9
and immunological responses in	9
the prevention of human	9
or confirmed cases of	9
the novel human coronavirus	9
drugs for treatment of	9
coronavirus antibody reactors among	9
the treatment of patients	9
the median time from	9
of viral excretion in	9
were tested for mers	9
from camels to humans	9
the sars coronavirus from	9
in the human population	9
syndrome coronavirus to the	9
metaphor of the sick	9
the critical care response	9
with the novel coronavirus	9
related to the sars	9
after the onset of	9
occurred in saudi arabia	9
single hospital in south	9
observed in the lungs	9
critical care response to	9
from asymptomatic infection to	9
syndrome generation of a	9
sars coronavirus from animals	9
day mortality in mers	9
preliminary epidemiological assessment of	9
cluster of novel coronavirus	9
to that of the	9
the development of the	9
within a family cluster	9
posterior probability of influenza	9
implications for pathogenesis and	9
environmental contamination and viral	9
possible cause of severe	9
from oman to united	9
coronavirus infection in humans	9
preliminary report of two	9
play a role in	9
south korea and china	9
of omsk hemorrhagic fever	9
east respiratory syndrome clinical	9
possibly linked to infected	9
characterization of viruses related	9
as well as a	9
a case fatality rate	9
of clinically developed drugs	9
among camels in dubai	9
intensive care unit in	9
the control of the	9
preventive treatment for middle	9
and the number of	9
reported cases of mers	9
study of patients presenting	9
imported from oman to	9
this work was supported	9
lack of middle east	9
treatment outcomes for patients	9
reactors among camels in	9
transmission in healthcare settings	9
and control guidelines for	9
b as primary and	9
prevention and control recommendations	9
israel epi isl israel	9
in human dipeptidyl peptidase	9
options for middle east	9
mers coronavirus middle east	9
respiratory tract and lungs	9
as a cause of	9
reduce the risk of	9
potent neutralization of middle	9
viruses related to the	9
detection of viral rna	9
coronavirus from animals in	9
the final version to	9
sequencing and phylogenetic analysis	9
respiratory syndrome coronavirus genome	9
polymerase chain reaction assays	9
severe acute respiratory and	9
widespread infection and alveolar	9
first cases of middle	9
median incubation period was	9
a mortality rate of	9
spread in a single	9
cases reported to who	9
originating from a camel	9
sample originating from a	9
should be noted that	9
a single patient in	9
the incubation period was	9
final version to be	9
south korea and taiwan	9
coronavirus disease in children	9
in the majority of	9
not included in the	9
were isolated from the	9
discovery of middle east	9
the sea of okhotsk	9
more closely related to	9
may be due to	9
saudi arabia and the	9
was isolated in from	9
intellectual content and approval	9
and serological analysis of	9
of emerging infectious diseases	9
the middle east region	9
ill patients with the	9
antibody reactors among camels	9
large case control study	9
coronavirus infection case on	9
treatment for middle east	9
turkey epi isl turkey	9
upper respiratory tract infection	9
most of the cases	9
the aim of this	9
king abdulaziz medical city	9
case control study of	9
further studies are needed	9
content and approval of	9
dromedary camels antibodies against	9
macaque and common marmoset	9
ticks collected in the	9
the northern part of	9
produced by infection of	9
viral shedding in mers	9
owned by an infected	9
with ili at a	9
responses to mers coronavirus	9
coronavirus referral center in	9
surveillance for middle east	9
in vitro activity against	9
of the manuscript for	9
an animal model of	9
coronavirus to the united	9
or acute respiratory distress	9
dromedary camels are the	9
east respiratory syndrome corona	9
characterisation of assay specificity	9
implications for the prevention	9
patients representing a broad	9
syndrome coronavirus infection among	9
time reverse transcription pcr	9
epidemiological investigation of mers	9
the causative agent of	9
respiratory syndrome coronavirus date	9
human transmission has been	9
a triple combination antiviral	9
respiratory syndrome coronavirus to	9
of infection with mers	9
t cells and macrophages	9
of ribavirin and interferon	9
sectional surveillance of middle	9
domain in middle east	9
outcomes for patients with	9
a coronavirus referral center	9
on a triple combination	9
circulation of influenza a	9
study was approved by	9
and indirect contact with	9
contamination and viral shedding	9
east respiratory syndrome is	9
in severe acute respiratory	9
well as in the	9
approval of the final	9
the authors and do	9
neutralization of middle east	9
a recent middle east	9
experimentally infected with mers	9
vitro activity against mers	9
infection in the republic	9
spectrum of disease severity	9
of viruses related to	9
cases were reported in	9
it is necessary to	9
air sample originating from	9
the sick man of	9
the disease outbreak news	9
as a reservoir for	9
in a single hospital	9
near the arabian peninsula	9
of icu admission and	9
from a patient with	9
be due to the	9
coronavirus by human monoclonal	9
discovery of a novel	9
barn owned by an	9
comparative and kinetic analysis	9
in mers patients representing	9
person transmission within a	9
responses in mers patients	9
novel human betacoronavirus c	9
for treatment of middle	9
characteristics and outcomes of	9
for transmission of middle	9
respiratory syndrome coronavirus an	9
ill patients with mers	9
infection at a coronavirus	9
respiratory syndrome generation of	9
family cluster of novel	9
and the united states	9
syndrome coronavirus genome in	9
in the comparator group	9
excretion in biological specimens	9
lungs of dromedary camels	9
the virus has been	9
oman to united arab	9
by a group of	9
as shown in table	9
cov antibodies in dromedary	9
in response to the	9
the discovery of the	9
the detection of the	9
the severity of illness	9
and lungs of dromedary	9
patients presenting with ili	9
animals in southern china	9
case on a triple	9
factors for transmission of	9
the fatal and nonfatal	9
is important for the	9
syndrome coronavirus antibody reactors	9
from onset to confirmation	9
risk of middle east	9
use of mechanical ventilation	9
transmission within a family	9
time reverse transcription polymerase	9
viral shedding and immunological	9
a single hospital in	9
viral rna in the	9
a camel barn owned	9
the s protein is	9
version to be published	9
shedding and immunological responses	9
critical revision of the	9
broad spectrum of disease	9
and preventive treatment for	9
causes widespread infection and	9
amino acid sequences of	9
an imported case of	9
cov spread in a	9
representing a broad spectrum	9
serological analysis of a	9
the bronze age in	9
rhesus macaque and common	9
and approval of the	9
syndrome coronavirus infection case	9
outside of the middle	9
the manuscript for important	9
arabia evidence for camel	9
and their role in	9
and characterisation of assay	9
infection case on a	9
from a camel barn	9
those who did not	9
cov referral hospital in	9
summary and literature update	9
a descriptive study clinical	9
or near the arabian	9
the treatment of severe	9
authors read and approved	9
study hospital outbreak of	9
the presence of viral	9
at high risk for	9
in the evolution of	9
sensitivity and specificity of	9
east respiratory syndrome generation	9
and other mammals in	9
coronavirus infection in saudi	9
classification and nomenclature of	9
kinetic analysis of viral	9
plaque reduction neutralization test	9
number of mers cases	9
for the spread of	9
developed drugs for treatment	9
infection in humans possibly	9
coronavirus infection during the	9
presenting with ili at	9
and kinetic analysis of	9
investigations and implications for	9
primary and preventive treatment	9
recent middle east respiratory	9
humans possibly linked to	9
in south korea and	9
a tertiary care hospital	9
and do not necessarily	9
tract and lungs of	9
in humans possibly linked	9
japan and south korea	9
a randomized controlled trial	9
risk factors associated with	9
important intellectual content and	9
by an infected patient	9
shedding in mers patients	9
analysis of a recent	9
at a coronavirus referral	9
ili at a mers	9
coronavirus as a possible	9
authors and do not	9
genome in an air	9
analysis of viral shedding	9
the host immune response	9
important role in the	9
is a type i	9
other mammals in egypt	9
a patient with severe	9
dromedary camels and other	9
in an air sample	9
repurposing of clinically developed	9
of the final version	9
from animals in southern	9
mers patients representing a	9
coronavirus genome in an	9
to a lesser extent	9
dromedary camels in abu	9
camel barn owned by	9
therapeutic options for middle	9
direct or indirect contact	9
of the european part	9
s subunit of the	9
spike protein of sars	9
immunological responses in mers	9
of rhesus macaques with	9
group than in the	9
virological and serological analysis	9
and viral shedding in	9
clinically developed drugs for	9
for important intellectual content	9
manuscript for important intellectual	9
screening of an fda	9
viral excretion in biological	9
of a recent middle	9
contact with a confirmed	9
in the course of	9
infection in livestock dromedaries	9
to united arab emirates	9
camels in abu dhabi	9
a large case control	9
in contrast to the	9
sick man of east	9
saudiarabia epi isl saudiarabia	9
during the sars outbreak	9
the emerging novel human	9
report of cases from	9
are potent inhibitors of	9
epidemiological assessment of mers	9
exceptionally potent neutralization of	9
pcr assay panel for	9
pattern of viral excretion	9
coronavirus infection in livestock	9
summary and risk assessment	9
camels and other mammals	9
to the sars coronavirus	9
the middle east is	9
an air sample originating	9
authors would like to	9
as primary and preventive	9
of the amino acid	9
unitedarabemirates epi isl unitedarabemirates	9
east respiratory syndrome coronaviruses	9
amount of viral rna	9
use of convalescent plasma	9
prevention and control practices	9
admitted to the icu	9
and control recommendations for	9
that there is a	8
response by the novel	8
saudi intensive care unit	8
care response to a	8
the identification of the	8
characteristics and public health	8
and public health implications	8
infection in the kingdom	8
factors and determinants of	8
lung pathology in rhesus	8
analysis of novel human	8
influenza other respir viruses	8
to mers coronavirus infection	8
shedding dromedaries at slaughterhouse	8
antibody specifically targeting receptor	8
the median time to	8
of patients with sars	8
potent inhibitors of middle	8
of human neutralizing antibodies	8
with a mortality rate	8
transmit the virus to	8
camels or their waste	8
management of patients with	8
the highest number of	8
the authors would like	8
an independent risk factor	8
did not result in	8
for the care and	8
for pathogenesis and treatment	8
of serologic responses to	8
in this article are	8
respiratory syndrome severe acute	8
spread of the virus	8
mers produced by infection	8
slaughterhouse with a potential	8
in the middle of	8
collected according to local	8
of convalescent plasma and	8
mice infected with middle	8
the western part of	8
syndrome in saudi intensive	8
presentation and outcome of	8
of ebola virus disease	8
epidemiological link to human	8
on the spike protein	8
stillbirth during infection with	8
were not detected in	8
in the caspian sea	8
respiratory syndrome coronavirus patients	8
the number of infected	8
receptor binding domain of	8
dromedary camels in nigeria	8
cases of novel coronavirus	8
by infection of rhesus	8
in saudi intensive care	8
excretion and subclinical infection	8
during middle east respiratory	8
dromedary camels mers coronavirus	8
tylonycteris bat coronavirus hku	8
cov shedding dromedaries at	8
mediated by the viral	8
a p value of	8
the care and use	8
the first imported mers	8
investigation of an imported	8
and subclinical infection with	8
a potential source of	8
for up to days	8
high prevalence of mers	8
dromedaries and risk for	8
been in contact with	8
syndrome coronavirus infections hospital	8
the incubation period of	8
local customs from dromedary	8
subunit of the mers	8
asymptomatic middle east respiratory	8
dependent neutralizing monoclonal antibody	8
syndrome coronavirus infection by	8
potential epidemiological link to	8
shedding in the respiratory	8
was defined as the	8
during infection with middle	8
infection in healthcare workers	8
cov global summary and	8
were euthanized on day	8
and outcome of middle	8
n strain was isolated	8
patient with middle east	8
identification of human neutralizing	8
multiple generations of secondary	8
kinetics of serologic responses	8
animal models of mers	8
response to a hospital	8
resulted in a significant	8
in the control groups	8
specific human monoclonal antibody	8
outbreaks in the near	8
of innate antiviral response	8
the source of the	8
the horn of africa	8
care and use of	8
damage in human lungs	8
to reduce the risk	8
contact investigation of a	8
serum samples were tested	8
of rhesus macaques and	8
in critically ill patients	8
to local customs from	8
from saudi arabia reported	8
chain reaction assays for	8
respiratory syndrome coronavirus treatment	8
the ark of the	8
the decision to submit	8
ankara delivering middle east	8
rna and neutralising antibodies	8
neutralising antibodies in milk	8
the basic reproduction number	8
close contact with a	8
aim of this study	8
the focal outbreak hospital	8
as a natural antagonist	8
vaccinia virus ankara delivering	8
with a middle east	8
loads in the lungs	8
in virus adaptive evolution	8
ark of the covenant	8
was first identified in	8
patients with respiratory symptoms	8
in a german hospital	8
countries in the arabian	8
lack of mers coronavirus	8
prevention and control of	8
between the two groups	8
acute respiratory infections in	8
syndrome coronavirus disease in	8
no potential conflicts of	8
by the novel middle	8
the early stage of	8
virus ankara delivering middle	8
their role in virus	8
coronavirus infection in rabbits	8
phylogenetic analysis of novel	8
across the arabian peninsula	8
a major outbreak of	8
of a patient with	8
cov in the middle	8
have contributed to the	8
in the late bronze	8
models of middle east	8
to illness onset among	8
of the disease and	8
in mers patients during	8
have been developed and	8
the respiratory tract tissues	8
human neutralizing antibodies against	8
the blood of patients	8
respiratory syndrome coronavirus the	8
on the arabian peninsula	8
as severe acute respiratory	8
transmission in health care	8
assay panel for middle	8
a case of long	8
deep sequencing and phylogenetic	8
clinical and survival data	8
the etiological agent of	8
animal care and use	8
the treatment of sars	8
the th of may	8
the virus was first	8
cases from saudi arabia	8
a high rate of	8
of the volga delta	8
with the help of	8
cytokines and suppression of	8
from a tertiary care	8
alveolar damage in human	8
of arboviruses in the	8
inflammatory cells in the	8
for probable or confirmed	8
was approved by the	8
imported case in china	8
human to human transmission	8
role in virus adaptive	8
been reported in the	8
has been found to	8
workers in saudi arabia	8
the result of the	8
link to human cases	8
with a potential epidemiological	8
the lungs of common	8
occupational exposure to dromedaries	8
in the management of	8
mycophenolic acid are potent	8
occurred in south korea	8
identified in saudi arabia	8
approved compound library identifies	8
severe acute respiratory illness	8
and pipistrellus bat coronavirus	8
respiratory syndrome in saudi	8
in agreement with the	8
viral shedding in the	8
dromedary camels in tabuk	8
a polyprotein precursor of	8
the south of the	8
customs from dromedary camels	8
syndrome severe acute respiratory	8
outcome of middle east	8
high viral loads in	8
suppression of innate antiviral	8
at slaughterhouse with a	8
disease outbreak news on	8
panel for middle east	8
in milk collected according	8
the index case was	8
biological specimens of two	8
and mycophenolic acid are	8
compound library identifies four	8
in saudi arabia epidemiological	8
with a history of	8
the virus in the	8
major outbreak of severe	8
dromedaries at slaughterhouse with	8
in biological specimens of	8
host innate immune response	8
to dromedaries and risk	8
and c bl mice	8
of the h n	8
clinical signs of disease	8
according to local customs	8
cov targeting the receptor	8
the risk of acquiring	8
the main operating room	8
and nomenclature of viruses	8
influenza a viruses among	8
pp a and pp	8
severe respiratory disease in	8
severe respiratory disease associated	8
the volga river delta	8
in jordan middle east	8
innate antiviral response by	8
syndrome coronavirus patients admitted	8
and alveolar damage in	8
countries in or near	8
day of symptom onset	8
were isolated from i	8
in the general population	8
clinical features of patients	8
have been isolated from	8
respiratory distress syndrome and	8
care unit in jeddah	8
antiviral response by the	8
mice infected with mers	8
is part of the	8
the emergence of sars	8
exposure to dromedaries and	8
milk collected according to	8
of the e gene	8
on the use of	8
of d and g	8
h n strain was	8
mers patients during mers	8
independent risk factor for	8
of the upper respiratory	8
animal models of middle	8
coronavirus causes widespread infection	8
commonwealth of independent states	8
bat coronavirus hku and	8
acute respiratory and emerging	8
for detection of middle	8
delayed induction of proinflammatory	8
infections have been reported	8
term excretion and subclinical	8
and risk for mers	8
spike protein of middle	8
from animals to humans	8
jordan middle east respiratory	8
syndrome coronavirus in cell	8
was defined as a	8
cov and their role	8
case fatality rate was	8
based middle east respiratory	8
kinetics and pattern of	8
emergence of the middle	8
respiratory and emerging infection	8
specimens of two mers	8
intensive care unit patients	8
and bronchial epithelial cells	8
in health care facilities	8
in the arab middle	8
macaques with mers coronavirus	8
update middle east respiratory	8
data collection and analysis	8
specific antibodies in dromedary	8
chadox mers with tpa	8
proinflammatory cytokines and suppression	8
coronavirus patients admitted to	8
infection of rhesus macaques	8
of novel human betacoronavirus	8
of an imported case	8
induction of proinflammatory cytokines	8
time reverse transcriptase polymerase	8
as the number of	8
the nucleocapsid protein of	8
acid are potent inhibitors	8
high fatality rates and	8
antibodies in milk collected	8
severity of the disease	8
threat to public health	8
risk of transmission of	8
combination of ribavirin and	8
east respiratory syndrome at	8
of mers produced by	8
of patients with severe	8
of birds in the	8
contact with the patient	8
a potential epidemiological link	8
risk factors and determinants	8
influenza a and b	8
infection and alveolar damage	8
and neutralising antibodies in	8
in one of the	8
of convalescent plasma therapy	8
tested negative for mers	8
and emerging infection consortium	8
syndrome coronavirus causes widespread	8
were found in the	8
in the spread of	8
isolated from the blood	8
high proportion of mers	8
the s and s	8
the transmission of middle	8
emerging human middle east	8
viruses and viral infection	8
polyprotein precursor of the	8
serologic responses to mers	8
open reading frame a	8
and pattern of viral	8
coronavirus infection by anti	8
study from saudi arabia	8
structural and accessory proteins	8
seroepidemiology of middle east	8
neutralizing antibody against mers	8
and suppression of innate	8
epithelial cells of the	8
syndrome coronavirus in al	8
model of mers produced	8
food and drug administration	8
deaths have been reported	8
the date of symptom	8
rhesus macaques with mers	8
humanized neutralizing antibody against	8
arabia and south korea	7
the city health department	7
pathology in rhesus monkeys	7
coronavirus infection treated in	7
of human novel coronavirus	7
respiratory syndrome coronavirus hospital	7
in a hospital in	7
crystal structure of the	7
in camel workers in	7
related betacoronavirus in vespertilio	7
possible genetic recombination of	7
is known to be	7
the health care setting	7
children middle east respiratory	7
in survival rates by	7
evidence for bats as	7
as soon as possible	7
coronavirus in young dromedary	7
and the presence of	7
are at high risk	7
risk factors for mortality	7
case clusters of middle	7
antagonist for dipeptidyl peptidase	7
the north of the	7
syndrome in two hospitals	7
common marmoset animal models	7
in saudi arabia clinical	7
of the virus from	7
mammalian and avian coronaviruses	7
is rare in children	7
burden of middle east	7
immunoglobulin for the treatment	7
a large outbreak in	7
zoonoses of northern eurasia	7
coronavirus in hafr al	7
emerging human coronaviruses by	7
phase i clinical trial	7
novel coronavirus infection treated	7
patients infected with mers	7
of alphacoronavirus and betacoronavirus	7
participated in data collection	7
systematic reviews and meta	7
coronavirus hku in japanese	7
in terms of the	7
hku and pipistrellus bat	7
genome analysis and virus	7
subclinical infection with middle	7
and mva based vaccine	7
prior to the onset	7
with a median age	7
virus ankara efficiently induces	7
the samsung medical center	7
to emergence of middle	7
that dromedary camels are	7
syndrome coronavirus from the	7
a high degree of	7
has a single orf	7
severity of middle east	7
of hospitalized patients with	7
systematic review and exploratory	7
the south korea outbreak	7
with a combination of	7
and horses with mers	7
syndrome coronavirus vaccine in	7
in type ii pneumocytes	7
divergence in the spike	7
seven novel mammalian and	7
risk of exposure to	7
cases of severe acute	7
national institutes of health	7
the amount of viral	7
coronavirus infection and public	7
case of imported middle	7
patients at increased risk	7
marked sequence divergence in	7
confirmed case of middle	7
the structural and accessory	7
avian coronaviruses in the	7
with human coronavirus oc	7
chains of middle east	7
experiencing symptoms and determining	7
infection rate of mosquitoes	7
susceptibility to middle east	7
and the development of	7
virus closely related to	7
two hospital outbreaks of	7
natural antagonist for dipeptidyl	7
syndrome coronavirus during pregnancy	7
much higher than that	7
university of hong kong	7
gene source of gammacoronavirus	7
differences in survival rates	7
and the pathogenesis of	7
on admission to the	7
acute respiratory syndrome vs	7
camels mers coronavirus in	7
that the virus has	7
acute respiratory illness in	7
emergence of a novel	7
in chinese horseshoe bats	7
of chikungunya virus in	7
can be divided into	7
eastern europe and the	7
reveals unique group and	7
to a hospital in	7
associated factors in two	7
origin of the novel	7
elicit neutralising antibodies and	7
precursor of the envelope	7
a case of human	7
unique group and subgroup	7
of cases of mers	7
clusters of middle east	7
compared to that in	7
deaminase acts as a	7
and public health response	7
is likely to be	7
from the lower respiratory	7
community case clusters of	7
sequence divergence in the	7
interim infection prevention and	7
domain complexed with human	7
and the commonwealth of	7
protects rabbits from mers	7
vaccine in balb c	7
in egypt middle east	7
days after experiencing symptoms	7
in jamaican fruit bats	7
an emerging infectious disease	7
to the lack of	7
respiratory infections of viral	7
the evolutionary source of	7
spike protein delivered by	7
hku in japanese pipistrelle	7
arboviral zoonoses of northern	7
of betacoronavirus lineage c	7
and aberrant induction of	7
based subunit vaccines against	7
guidelines for patients with	7
mva based vaccine candidates	7
than that in the	7
dromedary camels isolation of	7
in order to prevent	7
in the spring of	7
for emerging human coronaviruses	7
democratic republic of the	7
pneumonia patients at increased	7
hemorrhagic fever virus in	7
protein of pipistrellus bat	7
monoclonal antibody protects rabbits	7
there are a number	7
mediated entry of the	7
acute respiratory syndrome and	7
camels in the arabian	7
is a viral respiratory	7
group and subgroup features	7
of comorbidities in the	7
coronavirus from the first	7
group d coronaviruses reveals	7
source of gammacoronavirus and	7
camels in the human	7
at the samsung medical	7
are susceptible to mers	7
mice in the instillation	7
serology for emerging human	7
risk factors for adverse	7
of three novel group	7
the development of mers	7
of acute respiratory infections	7
of humans and dromedary	7
subclinical burden of middle	7
novel group c and	7
for the evaluation of	7
transmission middle east respiratory	7
the development of therapeutic	7
source of alphacoronavirus and	7
of mers coronavirus middle	7
of mers in daejeon	7
birds in the ussr	7
to the emergence of	7
after experiencing symptoms and	7
recovery from severe novel	7
cluster of cases of	7
a natural antagonist for	7
survival rates in mers	7
hospitals initiated by a	7
and clinical description middle	7
aquatic and semiaquatic birds	7
in the volga river	7
of the end of	7
associated with a high	7
comorbidities in the middle	7
antibody protects rabbits from	7
contact with a sick	7
been found to be	7
cases middle east respiratory	7
and associated factors in	7
the genus deltacoronavirus supports	7
first case of mers	7
protein delivered by modified	7
from sars to mers	7
regions of the world	7
twelve genomes of three	7
number of secondary cases	7
east respiratory syndrome coronovirus	7
human coronaviruses by protein	7
in a total of	7
epidemiological and clinical characteristics	7
a potential mechanism for	7
with a single dose	7
had at least one	7
human polyclonal immunoglobulin g	7
development of vaccines and	7
for mers coronavirus infection	7
were similar to those	7
a descriptive study hospital	7
illness associated with middle	7
of viruses of the	7
c viruses in bats	7
of patients with fever	7
was one of the	7
zoonotic middle east respiratory	7
control measures to prevent	7
evolutionary source of middle	7
neutralising antibodies and cellular	7
viral infection of human	7
genome deep sequencing and	7
death in the icu	7
in the process of	7
be detected in the	7
alpha a or ifn	7
library identifies four small	7
sars and mers coronaviruses	7
the aftermath of sars	7
an observational analysis with	7
reports from a tertiary	7
in a study of	7
europe and the commonwealth	7
and hyperimmune immunoglobulin for	7
corticosteroid therapy for critically	7
coronavirus and the multiple	7
result in productive viral	7
hospital middle east respiratory	7
able to replicate in	7
to that in the	7
vaccinia virus ankara efficiently	7
recombination of the middle	7
the virus was isolated	7
based vaccine candidates against	7
air and surrounding environment	7
risk of acquiring zoonotic	7
is caused by a	7
genus deltacoronavirus supports bat	7
number of cases in	7
in productive viral shedding	7
in mice transgenic for	7
of acute respiratory distress	7
of the sick man	7
analysis of data from	7
spike protein of pipistrellus	7
there were significant differences	7
of crimean hemorrhagic fever	7
polyclonal immunoglobulin g from	7
group c and group	7
was considered statistically significant	7
in the northern part	7
a comparison of the	7
cov infection in vitro	7
factors for mers coronavirus	7
host cell entry of	7
with human receptor dpp	7
first imported case in	7
estimating the severity and	7
history of contact with	7
from transchromosomic bovines inhibits	7
virus strains isolated from	7
increased risk of mers	7
case fatality rate of	7
factors in two hospital	7
egypt middle east respiratory	7
respiratory illness associated with	7
respiratory syndrome in two	7
the small number of	7
of the novel middle	7
estimating survival rates in	7
the use of a	7
the severity and subclinical	7
ministry of health in	7
days before symptom onset	7
confirmed cases have been	7
and days after experiencing	7
cov infection in dialysis	7
was higher than that	7
infections middle east respiratory	7
comparative analysis of twelve	7
coronavirus spike protein delivered	7
one or more of	7
the prior probability of	7
coronaviruses in the genus	7
in young dromedary camels	7
the central nervous system	7
the international health regulations	7
to the fact that	7
by a single patient	7
receptor and maintains broad	7
transchromosomic bovines inhibits mers	7
has also been found	7
and surrounding environment in	7
acts as a natural	7
an increased risk of	7
antibodies were found in	7
identified as h n	7
three novel group c	7
a decade after sars	7
review and exploratory meta	7
chadox and mva based	7
been reported from saudi	7
as well as other	7
coronaviruses reveals unique group	7
the united states of	7
not result in productive	7
total of patients were	7
acquiring zoonotic middle east	7
for human infection with	7
molecule inhibitors of middle	7
coronavirus infection in a	7
as the evolutionary source	7
coronavirus in a healthcare	7
association between severity of	7
infection treated in a	7
the commonwealth of independent	7
syndrome coronavirus in children	7
histopathology of middle east	7
the open reading frame	7
development and validation of	7
an increase in the	7
research and product development	7
for bats as the	7
the multiple generations of	7
of acquiring zoonotic middle	7
in the early stages	7
analysis with infection control	7
of an outbreak of	7
bats as the evolutionary	7
and group d coronaviruses	7
descriptive study hospital outbreak	7
risk factors for death	7
republic of the congo	7
syndrome at tertiary care	7
is in line with	7
influenza a virus strains	7
all authors read and	7
fatality rates and associated	7
have not yet been	7
in mammalian cell lines	7
initiated by a single	7
had been in contact	7
of cases and deaths	7
mers outbreak in the	7
two hospitals initiated by	7
be explained by the	7
severity and subclinical burden	7
syndrome coronavirus in hafr	7
illness onset among imported	7
immunogenicity of an adenoviral	7
of imported middle east	7
east respiratory coronavirus in	7
the efficacy of these	7
the first mers outbreak	7
survival rates by demographic	7
single patient in daejeon	7
in the disease outbreak	7
in vero e cells	7
based discovery of middle	7
arabia risk factors for	7
by modified vaccinia virus	7
saudi arabia world health	7
observational analysis with infection	7
case of human novel	7
surrounding environment in mers	7
and determinants of primary	7
mice transgenic for human	7
of twelve genomes of	7
hyperimmune immunoglobulin for the	7
who r d blueprint	7
cov was detected in	7
and viral infection of	7
of the virus into	7
and betacoronavirus and avian	7
plasma and hyperimmune immunoglobulin	7
from middle east respiratory	7
determining the differences in	7
respiratory coronavirus in young	7
rates by demographic data	7
of the novel coronavirus	7
are a number of	7
role in the evolution	7
virus isolated from the	7
incubation period of days	7
further evidence for bats	7
in the early stage	7
rna was extracted from	7
vaccine candidates against mers	7
median age of years	7
the korean mers outbreak	7
human and animal health	7
induction of inflammatory cytokines	7
strict implementation of infection	7
infection of human and	7
saudi arabia mers coronavirus	7
encodes a polyprotein precursor	7
in the arab region	7
and common marmoset animal	7
and subclinical burden of	7
dromedary camels in jordan	7
bat coronavirus hku in	7
of patients in the	7
and avian coronaviruses in	7
are shown in table	7
has yet to be	7
borne encephalitis virus in	7
cov in dromedary camels	7
organization of the united	7
lower respiratory tract and	7
characterization of betacoronavirus lineage	7
for human dipeptidyl peptidase	7
is considered to be	7
coronavirus transmission from infected	7
in a healthcare worker	7
united states of america	7
during the outbreak of	7
with mg of m	7
high risk of mers	7
this article can be	7
eastern respiratory syndrome corona	7
in vespertilio superans bats	7
the who r d	7
in combination with other	7
the clinical symptoms of	7
cells in the lungs	7
of various risk factors	7
cov elicit neutralising antibodies	7
broad replicative capability in	7
of the bunyaviridae family	7
acute respiratory infections of	7
treated in a german	7
lower respiratory tract infections	7
or more of the	7
in dromedary camels antibodies	7
implementation of infection control	7
antibodies and cellular immune	7